# Nivolumab

## Opdivo inj 100mg-10mL

*藥物代碼*：IOPD

*給藥途徑*：I

*用法用量*：

Administer by intravenous infusion based upon recommended infusion rate for each indication.
Unresectable or metastatic melanoma: 240 mg every 2 weeks or 480 mg every 4 weeks. 1 mg/kg followed by ipilimumab 3 mg/kg on the same day every 3 weeks for 4 doses, then 240 mg every 2 weeks or 480 mg every 4 weeks.
Adjuvant treatment of melanoma: 240 mg every 2 weeks or 480 mg every 4 weeks.
Metastatic non-small cell lung cancer: 3 mg/kg every 2 weeks with ipilimumab 1 mg/kg every 6 weeks. 360 mg every 3 weeks with ipilimumab 1 mg/kg every 6 weeks and 2 cycles of platinum-doublet chemotherapy. 240 mg every 2 weeks or 480 mg every 4 weeks.
Malignant pleural mesothelioma: 360 mg every 3 weeks with ipilimumab 1 mg/kg every 6 weeks.
Advanced renal cell carcinoma: 3 mg/kg followed by ipilimumab 1 mg/kg on the same day every 3 weeks
for 4 doses, then 240 mg every 2 weeks or 480 mg every 4 weeks. 240 mg every 2 weeks or 480 mg every 4 weeks administered in combination with cabozantinib 40 mg once daily without food. 240 mg every 2 weeks or 480 mg every 4 weeks.
Classical Hodgkin lymphoma: 240 mg every 2 weeks or 480 mg every 4 weeks.
Recurrent or metastatic squamous cell carcinoma of the head and neck: 240 mg every 2 weeks or 480 mg every 4 weeks.
Locally advanced or metastatic urothelial carcinoma: 240 mg every 2 weeks or 480 mg every 4 weeks.
Microsatellite instability-high (MSI-H) or mismatch repair deficient: (dMMR) metastatic colorectal cancer. Adult and pediatric patients ? 40 kg: 240 mg every 2 weeks or 480 mg every 4 weeks.  Pediatric patients < 40 kg: 3 mg/kg every 2 weeks. Adult and pediatric patients ? 40 kg: 3 mg/kg followed by ipilimumab. 1 mg/kg on the same day every 3 weeks for 4 doses, then 240 mg every 2 weeks or 480 mg every 4 weeks. 
Hepatocellular carcinoma: 240 mg every 2 weeks or 480 mg every 4 weeks. 1 mg/kg followed by ipilimumab 3 mg/kg on the same day every 3 weeks
for 4 doses, then 240 mg every 2 weeks or 480 mg every 4 weeks.
Esophageal squamous cell carcinoma: 240 mg every 2 weeks or 480 mg every 4 weeks.

